WCI
검색
Login
Sign Up
Sitemap
About Us
Message from the President
Mission
History
Charter
Bylaws
Organization
Linkage with Other Organizations
Membership
Membership
Organization Members
Individual Members
Student Members
Honorary Members
ICI
ICI History
ICI Chronicles
ICI Documents
ICI Photos
Publications
Newsletters
Brochures
Annual Activity Reports
Minutes
Advisory Report
Training /
Seminar
Training Courses
Materials
Communication
Announcements
Events
RI Related News
RI Related News
Awards
Awards
Winners
Funding
Kinds of WCI funding
Acknowledgements
Community
RI Related News
RI Related News
Home > RI Related News > RI Related News
RI Related News
LOGIN
게시글 목록
No
TItle
Name
Date
Hit
800
Framatome to support Global Morpho Pharma’s high-capacity technology development for Lutetium-177 separation
WCI Secretariat
2024/01/08
1603
799
IBA, CMI and Life Molecular Imaging announced Japanese approval for the reimbursement of amyloid-PET diagnostic Neuraceq® in Alzheimer's disease
WCI Secretariat
2024/01/08
1468
798
GT Medical Technologies, Inc. Agrees to Acquire Radioactive Seed Assets from Perspective Therapeutics, Inc.
WCI Secretariat
2024/01/08
1443
797
Perspective Therapeutics Announces Results of the Study of [(212)Pb]VMT-α-NET to Treat Refractory or Relapsed Neuroendocrine Tumors
WCI Secretariat
2024/01/08
1449
796
Philochem and Blue Earth Diagnostics Announced First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors
WCI Secretariat
2024/01/08
1416
795
Clarity Pharmaceuticals Commences Phase III Trial in Prostate Cancer
WCI Secretariat
2024/01/08
1443
794
Novartis to invest in a new manufacturing facility in China to accelerate the introduction of innovative radioligand therapies
WCI Secretariat
2024/01/08
1508
793
New SCK CEN Production Facility To Help more Cancer Patients
WCI Secretariat
2024/01/08
1432
792
Fusion Pharmaceuticals Announces Presentation Of Preclinical Data Supporting FPI-2068, A Novel Targeted Alpha Therapy For EGFR-CMET Expressing Cancers
WCI Secretariat
2023/11/09
1525
791
RAD receives approval for Phase 1 therapeutic study of PDL1-nanobody in Non-Small Cell Lung Cancer
WCI Secretariat
2023/11/09
1489
790
RAYZEBIO to Participate in the Inaugural CDRP Program to Expedite Commercial Manufacturing Readiness for treatment of GEP-NETS
WCI Secretariat
2023/11/09
1517
789
SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers
WCI Secretariat
2023/11/09
1532
788
Eckert & Ziegler and PharmaLogic Sign Reservation Agreement for Supply of Therapeutic Radioisotope Actinium-225
WCI Secretariat
2023/11/09
1559
787
Laurentis Energy Partners and S.N. Nuclearelectricia S.A Spearhead International Collaboration to Advance the Production of Medical Isotopes in Romania
WCI Secretariat
2023/11/09
1651
786
ITM and CNL Announce the Launch of Actineer, a New Joint Venture in the Global Production of Actinium-225
WCI Secretariat
2023/11/09
1693
First
Prev
1
2
3
4
5
6
7
8
9
10
Next
End (55 Page)
Name
Title
Contents
비밀글입니다!
글작성시 입력했던 비밀번호를 입력해주세요.
비밀번호 입력